The updated lithium kit from Randox is intended for the quantitative in vitro determination of lithium in serum and is suitable for use on a range of clinical analysers.
The reagent is liquid stable and offers an improved open-vial stability of 14 days at 10C.
Other features include a measuring range of 0.281-3.00mmol/l, high precision, traceability to the NIST reference method and limited interference from Bilirubin, Triglycerides and Haemoglobin.
Randox provide a range of other tests for monitoring the use of drugs with very small therapeutic ranges.
Tests include: Digoxin, Gentamicin, Phenytoin, Theophylline, Valproic acid, Phenobarbital and Carbamazepine.
In addition to this, Randox can also provide therapeutic drug-quality controls.
The company's therapeutic drug controls are 100 per cent human in origin and contain a comprehensive menu of 18 analytes with accurately assigned method-specific target values and ranges quoted for the most common instruments and methods.